Jinhe Biotechnology CO., LTD. (SHE:002688)
6.33
+0.04 (0.64%)
Feb 4, 2026, 2:45 PM CST
SHE:002688 Revenue
Jinhe Biotechnology CO., LTD. had revenue of 645.94M CNY in the quarter ending September 30, 2025, with 9.20% growth. This brings the company's revenue in the last twelve months to 2.75B, up 21.58% year-over-year. In the year 2024, Jinhe Biotechnology CO., LTD. had annual revenue of 2.37B with 9.04% growth.
Revenue (ttm)
2.75B
Revenue Growth
+21.58%
P/S Ratio
1.72
Revenue / Employee
1.11M
Employees
2,476
Market Cap
4.73B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.37B | 196.50M | 9.04% |
| Dec 31, 2023 | 2.17B | 51.43M | 2.42% |
| Jan 1, 2023 | 2.12B | 44.72M | 2.15% |
| Jan 1, 2022 | 2.08B | 263.35M | 14.51% |
| Dec 31, 2020 | 1.81B | 32.27M | 1.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jinling Pharmaceutical Company | 3.13B |
| Tianjin Tianyao Pharmaceuticals | 2.87B |
| Zhejiang Starry Pharmaceutical | 2.39B |
| Yabao Pharmaceutical Group | 2.27B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 1.74B |
| Ningbo Menovo Pharmaceutical | 1.54B |
| Tibet Weixinkang Medicine | 1.17B |
| LanZhou Foci Pharmaceutical | 895.75M |